Sarcomatoid carcinoma of the lung screening: Difference between revisions
Trushatank (talk | contribs) Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Trusha}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guideline n..." |
Trushatank (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{Trusha}} | |||
==Overview== | ==Overview== | ||
Revision as of 15:21, 2 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Trusha Tank, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]